v3.26.3
Consolidated Statements of Cash Flows (unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (30,308,379) $ (15,293,011)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 374,814 238,147
Amortization of debt discount, issuance costs and warrants 499,845
Changes in fair value of warrant liability (1,424,603)
Shares issued for services 1,004,319 595,841
Commitment shares issued for equity line of credit 568,235
Stock-based compensation expense 4,128,582 2,661,397
Loss on extinguishment of debt (Leonite settlement) 1,639,319
Issuance costs allocated to embedded derivative, expensed 76,114
Change in fair value of embedded derivative (62,000)
Changes in operating assets and liabilities:    
Prepaid expenses (525,994) 697,500
VAT receivable (900,333)
Accounts payable and accrued expenses 9,246,255 1,586,659
Accrued interest on convertible notes 111,726
Accrued payroll and payroll taxes (33,735) (138,495)
Net cash used in operating activities (14,749,467) (10,508,330)
CASH FLOWS FROM INVESTING ACTIVITIES    
Patent license acquisition (466,423)
Net cash used in investing activities (466,423)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from Leonite Note (net of $35,000 lender fees) 1,565,000
Proceeds from warrant exercises (net of issuance costs) 3,376,260 6,264,270
Proceeds from convertible notes (net of issuance costs) 4,025,000
Sale of preferred stock and warrants 1,053,582
Proceeds from issuance of common stock and warrants in connection with Registered Direct Offering (net of issuance costs) 4,820,389
Proceeds from at-the-market sales of common stock (net of commissions) 534,804
Proceeds from 2026 OID Secured Note Financing (net of issuance costs) 2,490,000
Repayment of Leonite Note (Settlement Payment) (1,900,000)
Net cash provided by financing activities 14,911,453 7,317,852
Net change in cash and cash equivalents 161,986 (3,656,901)
Cash and cash equivalents – beginning of period 269,830 5,533,527
Cash and cash equivalents – end of period 431,816 1,876,626
Cash paid for interest 14,000
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Warrants issued in connection with Convertible Bridge Notes 567,402
Conversion of Bridge Notes and accrued interest into common stock and warrants 1,348,523
Equity instruments issued with Leonite and Secured Notes 3,327,447
Common stock issued in settlement of Leonite Note, net of Commitment Shares Returned 366,750
Embedded derivative recognized at issuance of Secured Notes 949,000
Shares issued for prepaid services 1,100,713
Mezzanine equity conversion (net of costs) 3,730,121
Common stock issued for patent purchase 6,398,015
Reclassification of warrant liability to equity $ 878,153

Source